To further clarify genetic alterations, functions, and carcinogenic mechanisms of ATF3, we evaluated the frequency of ATF3 mutations in HCC and obtained an estimate of 10% based on publicly available data. This evidence concerns the gene ATF3 and hepatocellular carcinoma.